4.7 Article

Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice

Related references

Note: Only part of the references are listed.
Article Oncology

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity

Jamila Laoukili et al.

Summary: This study identifies the resistance of peritoneal metastases in colorectal cancer to oxaliplatin and links it to the specific molecular subtype and high reducing capacity. Inhibiting the reducing capacity may be an effective strategy to overcome oxaliplatin resistance in peritoneal metastases.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

Giovanni Fuca et al.

Summary: Peritoneal metastases and ascites are poor prognostic factors for patients with dMMR/MSI-H advanced gastrointestinal cancers receiving ICIs.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)

Koen P. Rovers et al.

Summary: This study aimed to evaluate the safety and antitumor activity of pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) as a palliative monotherapy for patients with unresectable colorectal peritoneal metastases. The results showed that some major adverse events occurred and minor adverse events were common in these patients, with uncertain clinical relevance of observed biochemical, pathological, and ascites responses.

ANNALS OF SURGICAL ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition

Kevin Litchfield et al.

Summary: Checkpoint inhibitors (CPIs) enhance adaptive immunity, with clonal tumor mutation burden (TMB) identified as the strongest predictor of CPI response. Dinucleotide variants may serve as a source of immunogenic epitopes, while copy-number alterations and HLA evolutionary divergence lack pan-cancer significance.
Article Multidisciplinary Sciences

Inference and analysis of cell-cell communication using CellChat

Suoqin Jin et al.

Summary: By constructing an interaction database and developing the tool CellChat, the authors quantitatively inferred and analyzed cell-cell communication networks, revealing important signaling inputs and outputs between cells, and achieved classification of conserved and context-specific pathways.

NATURE COMMUNICATIONS (2021)

Article Oncology

Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity

Andrew Chow et al.

Summary: The study revealed that metastatic cancer in the pleural and peritoneal cavities leads to poor clinical outcomes after immune checkpoint blockade therapy, mainly due to the high expression of Tim-4 by cavity-resident macrophages, which suppresses tumor-reactive CD8(+) T cells. Blocking Tim-4 can enhance the efficacy of immunotherapy in these microenvironments.

CANCER CELL (2021)

Article Multidisciplinary Sciences

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez et al.

NATURE (2020)

Article Multidisciplinary Sciences

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Rita Cabrita et al.

NATURE (2020)

Article Multidisciplinary Sciences

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink et al.

NATURE (2020)

Review Immunology

Tertiary lymphoid structures in cancer - considerations for patient prognosis

Luis Munoz-Erazo et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Article Medicine, General & Internal

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer

T. Andre et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Genetics & Heredity

Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids

Ana C. F. Bolhaqueiro et al.

NATURE GENETICS (2019)

Review Oncology

Tertiary lymphoid structures in the era of cancer immunotherapy

Catherine Sautes-Fridman et al.

NATURE REVIEWS CANCER (2019)

Article Oncology

The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors

Laetitia Marisa et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Oncology

The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors

Laetitia Marisa et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Oncology

Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer

Jonathan M. Loree et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Multidisciplinary Sciences

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Daniele V. F. Tauriello et al.

NATURE (2018)

Article Oncology

Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer

Jonathan M. Loree et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Multidisciplinary Sciences

Lineage tracking reveals dynamic relationships of T cells in colorectal cancer

Lei Zhang et al.

NATURE (2018)

Article Medicine, Research & Experimental

IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade

Mark Ayers et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

Article Multidisciplinary Sciences

Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids

Arianna Fumagalli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Biochemistry & Molecular Biology

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

Marc van de Wetering et al.

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Biochemistry & Molecular Biology

The Molecular Signatures Database Hallmark Gene Set Collection

Arthur Liberzon et al.

CELL SYSTEMS (2015)

Review Cell Biology

Regulation of Cellular Processes by Interleukin-16 in Homeostasis and Cancer

Jillian Richmond et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2014)

Article Biochemistry & Molecular Biology

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

Felipe De Sousa E Melo et al.

NATURE MEDICINE (2013)

Review Oncology

Toward a molecular classification of colorectal cancer: the role of BRAF

Alexandra Thiel et al.

FRONTIERS IN ONCOLOGY (2013)

Article Multidisciplinary Sciences

Comprehensive molecular characterization of human colon and rectal cancer

Donna M. Muzny et al.

NATURE (2012)

Article Medical Laboratory Technology

Advanced Colorectal Cancer Is Associated With Enhanced IL-23 and IL-10 Serum Levels

Noyko Stanilov et al.

LABMEDICINE (2010)

Article Oncology

Increased TGF-beta1 protein expression in patients with advanced colorectal cancer

Marcus Langenskiod et al.

JOURNAL OF SURGICAL ONCOLOGY (2008)